Lotte Knudsen

Lotte Knudsen is an influential figure at Novo Nordisk, a Danish pharmaceutical company, where she has been pivotal in the development of GLP-1-related drugs such as Ozempic and Wegovy. She shares the Breakthrough Prize in Life Sciences for her contributions to the advancement of treatments for obesity and diabetes.